Back to the OR?

Blood

Volumn 118, Issue 9, 2011, Pages 2386-

  Bacigalupo, Andrea ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; BONE MARROW; DONOR; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; NOTE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SIBLING;

EID: 80052396437     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362780     Document Type: Note

References (11)

1. Eapen M., Le Rademacher J., Antin J.H., et al. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood. 2011;118(9):2618-2621.
2. Schrezenmeier H., Passweg J.R., Marsh J.C., et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110:1397-1400. (Pubitemid 47281442)
3. Chu R., Brazauskas R., Kan F., et al. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for Patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2011;17(7):1018-1024.
4. Gluckman E., Horowitz M.M., Champlin R.E., et al. Bone marrow transplantation for severe aplastic anemia: Influenece of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992;79:269-275.
5. Halter J., Kodera Y., Ispizua A.U., et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94(1):94-101.
6. Storb R., Thomas E.D., Buckner C.D., et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974;43(2):157-180
7. Deeg H.J., Amylon I.D., Harris R.E., et al. Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001;7:208-215. (Pubitemid 32433247)
8. Kojima S., Matsuyama T., Kato S., et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: The Japan Marrow Donor Program. Blood. 2002;100:799-803. (Pubitemid 34832604)
9. Bacigalupo A., Tong J., Podestà M., et al. Bone marrow harvest for marrow transplantation: Effect of multiple small (2 mL) or large (20 mL) aspirates. Bone Marrow Transplant. 1992;9:467-470.
10. Storb R., Leisenring W., Anasetti C., et al. Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antitymocyte globulin. Blood. 1997;89:3899-3891.
11. Marsh J.C., Gupta V., Lim Z., et al. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia [published online ahead of print April 25, 2011]. Blood. doi: 10.1182/blood-2010-12-327536.